Mmcap International Inc. Spc Bria Cell Therapeutics Corp. Transaction History

Mmcap International Inc. Spc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 10, 2021	SELL	$4.4 - $9.28 $1.76 Million - $3.71 Million	-400,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.89 - $6.57 $1.16 Million - $2.63 Million	400,000 New	400,000 $2.13 Million

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $15.2M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Mmcap International Inc. Spc, based on Form 13F filings with the SEC.

Stay updated on Mmcap International Inc. Spc with notifications on news.